Profile (as of April 2021)
Company name | Lilac pharma Inc. |
Address | Room #C, Hokkaido Collaboration Center (Collabo Hokkaido Bldg.) North 21, West 12, Kita-ku, Sapporo, Hokkaido 001-0021, Japan |
Business | 1. Research and development of pharmaceutical products etc. 2. Licensing and trading intellectual properties. 3. Investigation and consultation pertaining to the research and development of pharmaceutical products etc. |
Date of establishment | April 18, 2016 |
Capital | 14.1 million yen |
Management | President Motoki Susa, PhD Director Makiyo Sato, lawyer Auditor Taihei Muramoto, SME Management Consultant |
Adviser | Hisao Shiozawa, Patent attorney, SIKS &Co. (IP firm) |
Employee | 3 |
History
Mar. 2016 | Awarded the Grand Prize in the SAPPORO Venture Grand Prix 2015 (in the name of Motoki Susa). |
Mar. 2016 | Awarded a grant of 35 million yen from the NEDO (New Energy and Industrial Technology Development Organization, Japan) (in the name of Hokkaido univ. entrepreneur team). |
Apr. 2016 | Established in Sapporo city. |
Jun. 2016 | Certified by Hokkaido University as a university spin-off company. |
Jan. 2018 | Raised 10 million yen in seed-round financing from Hokuyo fund. |
Apr. 2018 | iLiNP business launched. |